[HTML][HTML] Long-term interplay between COVID-19 and chronic kidney disease

H Schiffl, SM Lang - International Urology and Nephrology, 2023 - Springer
Purpose The COVID-19 pandemic may have an impact on the long-term kidney function of
survivors. The clinical relevance is not clear. Methods This review summarises the currently …

The role of kidney injury biomarkers in COVID-19

L Su, J Zhang, Z Peng - Renal Failure, 2022 - Taylor & Francis
Abstract The coronavirus disease-2019 (COVID-19) outbreak has been declared a global
pandemic. COVID-19-associated acute kidney injury (COVID-19 AKI) is related to a high …

[HTML][HTML] Association of serum vitamin D concentration with the final course of hospitalization in patients with COVID-19

K Konikowska, K Kiliś-Pstrusińska… - Frontiers in …, 2023 - frontiersin.org
Background Vitamin D deficiency is a substantial public health problem. The present study
evaluated the association between vitamin D concentration and hospitalization and mortality …

[HTML][HTML] Spectrum of kidney injury following COVID-19 disease: renal biopsy findings in a single Italian pathology service

A Gambella, A Barreca, L Biancone, D Roccatello… - Biomolecules, 2022 - mdpi.com
The onset of coronavirus disease (COVID-19) as a pandemic infection, has led to increasing
insights on its pathophysiology and clinical features being revealed, such as a noticeable …

[HTML][HTML] Cannabidiol and terpene formulation reducing SARS-CoV-2 infectivity tackling a therapeutic strategy

S Santos, P Barata, A Charmier, I Lehmann… - Frontiers in …, 2022 - frontiersin.org
In late 2019, COVID-19 emerged in Wuhan, China. Currently, it is an ongoing global health
threat stressing the need for therapeutic compounds. Linking the virus life cycle and its …

[HTML][HTML] Identification of common molecular signatures of SARS-CoV-2 infection and its influence on acute kidney injury and chronic kidney disease

W Zhang, L Liu, X Xiao, H Zhou, Z Peng… - Frontiers in …, 2023 - frontiersin.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the main cause of
COVID-19, causing hundreds of millions of confirmed cases and more than 18.2 million …

[HTML][HTML] High concentrations of nirmatrelvir/ritonavir in critically ill patients receiving continuous renal replacement therapy

R Dong, Y Huang, X Ling, L Li, W Yu, S Jiang - International Journal of …, 2024 - Elsevier
Objectives Nirmatrelvir/ritonavir is a highly efficacious agent against severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) infection. Although dose adjustment is …

COVID-19 and multiorgan response: the long-term impact

A Harky, A Ala'Aldeen, S Butt, B Duric, S Roy… - Current Problems in …, 2023 - Elsevier
In late December 2019, severe acute respiratory syndrome coronavirus type-2 (SARS-CoV-
2) was discovered following a cluster of pneumonia cases in Wuhan, China. During the early …

ANCA-associated vasculitis following the first dose of Pfizer-BioNTech COVID-19 vaccine

G El Hasbani, I Uthman - Nephron, 2023 - karger.com
Abstract Coronavirus disease (COVID-19) vaccine can alter the body's immunological
balance leading to autoimmune disease in rare cases. Anti-neutrophil cytoplasmic antibody …

[HTML][HTML] COVID-19 and chronic kidney disease: A narrative review

MP Martins, RB de Oliveira - COVID, 2023 - mdpi.com
The coronavirus disease-2019 (COVID-19) pandemic has had a profound impact on the
world, causing loss of life, economic damage, and social disruption. Individuals with chronic …